# Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

> **NCT01707394** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 49 (actual)

## Conditions studied

- Thromboembolism

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT01707394
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-10
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2021-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707394, "Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01707394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*